Clinical Trials Browser

Unknown × Prostatic Neoplasms × Injections × Clear all

NCT05856630 2023-05-12

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Phase 1 Unknown

Prostatic Neoplasms